Showing posts with label 劉奕宏. Show all posts
Showing posts with label 劉奕宏. Show all posts
Feb 13, 2020
Sep 18, 2019
2019/09/26 Journal Club
Tumor immune microenvironment characteristics of papillary thyroid carcinoma are associated with histopathological aggressiveness and BRAF mutation status.
Mar 14, 2019
2019/03/21 Journal Club
Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade.
Jul 4, 2018
2018/07/19 Journal Club
Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells.
Feb 13, 2018
2018/03/01 Journal Club
Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy.
Oct 19, 2017
2017/11/02 Journal Club
Identification of an atypical monocyte and committed progenitor involved in fibrosis.
(PubMed Link)
Yi-Hong Slide 瀏覽或下載連結
買一送一 ^^
Yi-Hong Slide 瀏覽或下載連結
買一送一 ^^
CCR2+ monocytic myeloid-derived suppressor cells (M-MDSCs) inhibit collagen degradation and promote lung fibrosis by producing transforming growth factor-β1.
Jul 13, 2017
2017/07/20 Journal Club
Enrichment of Human CCR6+ Regulatory T Cells with Superior Suppressive Activity in Oral Cancer.
(PubMed Link)Yi-Hong's slides : 按我預覽或下載
Apr 20, 2017
2017/04/27 Journal Club
PI3Kγ is a molecular switch that controls immune suppression.
(PubMed Link)
------------------------
Yi-Hongのslides <按我預覽或下載>
2017/06/26 Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells 講者:許銘娟 博士 ( Dr.洪副實驗室博士後研究員 後來颱風取消)
------------------------
Yi-Hongのslides <按我預覽或下載>
2017/06/26 Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells 講者:許銘娟 博士 ( Dr.洪副實驗室博士後研究員 後來颱風取消)
Jan 24, 2017
2017/02/02 Journal Club paper
Indomethacin Treatment of Mice with Premalignant Oral Lesions Sustains Cytokine Production and Slows Progression to Cancer.
< PubMed 連結> PMID: 27713748Sep 18, 2014
Subscribe to:
Posts (Atom)
